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Immunocytes with antiself activity can be  acquired experimentally if  lymphoid 
cells  from inbred animals are administered to their F1 hybrids. Infant recipients of 
parental cells are usually killed by an acute graft-versus-host reaction, but this seldom 
happens when the cells are injected into mature F1 hybrids. Instead, a chronic disorder 
resembling an autoimmune disease  often  develops.  Three  immunologic syndromes 
have been described thus far: immunohemolytic anemia (1)  and glomerulonephritis 
(2) in mice, and polyarthritis with dermatitis and carditis in rats (3, 4). Moreover, a 
high incidence of lymphomas occurs in (C57B1/6  X  DBA/2)F1 mice given C57B1/6 
spleen cells (5),  a combination in which the immunologic lesion is immunohemolytic 
anemia (1). The present experiments were undertaken in (BALB/c  X  A/J)F1 mice, 
which develop immune complex-mediated glomerulonephritis when inoculated with 
BALB/c spleen cells (2). Administration of parental cells to these hybrids triggered a 
sustained immunoproliferative  reaction, and eventually a high incidence of reticulum 
cell sarcomas developed. 
Materials and Methods 
Animds.--BALB/c,  A/J, and (BALB/c X  A/J)F1 (hereafter referred to as CAF1) mice 
were obtained from Jackson Laboratories, Bar Harbor, Maine. Many of the animals were bred 
in our laboratory from Jackson parental stocks. The mice were housed in plastic cages and fed 
standard  diets. Spleen cell donors were 6--8 wk old and the F1 recipients were 6 wk old at 
the time of the first injection of parental cells. 
Preparation of Spleen Cell Suspensions.---A previously described technique  (2)  was used. 
Histopathology.--Specimens of all visible lymph nodes, spleen, liver, small bowel, kidney, 
lung, and thymus were obtained at autopsy. Tissues were fixed in 10% buffered formalin and 
stained with hematoxylin and eosin. Classification of neoplasms followed the nomenclature 
of Dunn (6). 
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Electron Microscopy.--Fragments  of tissue were fixed for 30 min in 6.5% glutaraldehyde 
(7), postflxed with 1% osmium tetroxide buffered with 0.i ~  phosphate buffer (pH 7.2) and 
embedded in epon after dehydration in graded alcohols. Thick sections (0.5/z) were prepared 
to select blocks, which were then cut with glass knives on a Porter-Blum microtome. Ultrathin 
sections were mounted on uncoated grids, stained with lead citrate 0.4%  (8)  and examined 
with an RCA EMU 3-C electron microscope (50 kv, objective aperture 50 #). 
Tissue Transplantation.--Cell  suspensions containing 5-15  X  106 cells were prepared as 
described and injected intrapefitoneally into litters of 1- to 2-day-old mice. The  recipients 
were killed  and autopsied at the time of appearance of an obvious tumor, or no later than  1 
yr after they received the cell suspension. 
Cytotoxicity Assay.--A  method  based  on  the  release  of  radioisotope from  ~lCr-labeled 
mouse lymphocytes, described by Haughton (9) and Wigzell (10), was used. The tissue culture 
medium was Kaliss' buffer (11). Monospecific antisera against single H-2 specificifies  were 
TABLE  I 
Inc~ence ~  Lymphomasin Experimentd Mice 
No. of BALB/c spleen  cells  administered (X106) 
Age 
10  50  100  150  200 
months 
3-5  --  -  --  3/46  -- 
6  0/17  0/15  --  5/33  7/19 
12  0/19  2/17  3/14  20/73  19/44 
18  --  -  --  31/56  -- 
24  --  --  --  14/18  -- 
Numerator, number of neoplasms; denominator, total number of mice in the group. 
obtained from Dr. George Snell, Bar Harbor, Maine. Tumor cells previously frozen at --90°C 
were tested for their ability to absorb antibody activity from the monospecific antisera. The 
antiserum was diluted so as to produce about 80% of the maximum ~lCr released from labeled 
target cells.  Suspensions containing increasing numbers of tumor cells  (in 25 #I)  or normal 
cells were added to the selected dilution of antiserum (i.e., that dilution producing 800/o of the 
maximum release of 51Cr from the target cells). The mixture was incubated for 15 min, after 
which labeled target cells  and complement (selected normal rabbit serum) were added. In 
five instances fresh tumor cells labeled with 51Cr were used as the target cells. Tumors selected 
for analysis by this method consisted of a solid mass of neoplastic tissue.  Particular care was 
taken to exclude from study any tumors embedded in or surrounded by normal-appearing 
(by gross and microscopic examination) lymphoid tissue. 
Assays for Chimerism. The spleen assay (12, 13) method of Simonsen and Jensenwas used. 
RESULTS 
Control Mice.  There  were 324  control CAF1 mice,  of which  241  were  un- 
treated, 45  were injected with  150  X  106  syngeneic spleen cells, and 38  were 
inoculated with  150  X  106  frozen and  thawed BALB/c  spleen cells. The  241 
untreated animals were killed when 6, 12, 18, or 24 months old. These subgroups 
contained 58, 50, 68, and 65 mice respectively. The 45  CAF1 mice treated with 
150  >(  106 syngeneic spleen cells were killed when 6  (16 mice)  or 12  (29 mice) ARMSTRONG  ET  AL.  419 
months old. The third group of control CAF1 mice, which were injected with 
150 X  106 BALB/c spleen cells that had been subjected to three cycles of freez- 
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FIG. 1. Body weights of control  (O--O)  and experimental  ( tl--  0) animals. In this and 
succeeding figures, the horizontal  bars indicate  1 SE. 
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FIo. 2. Spleen weights of CAF1 mice 1 yr after receiving the indicated amounts of BALB/c 
spleen cells. 
ing and thawing, was killed at 6  (16 mice)  or 12  (22 mice) months of age. As 
there were no differences  among the various groups with regard  to body and 
organ weights,  histology, and tumor incidence,  the results  were pooled  (Figs. 
1-4, 7-9. 
54 BALB/c mice were autopsied,  25 at the age of 1 yr and 29 at the age of 420  CHRONIC  ALLOGENEIC DISEASE.  II 
18 months. Three  (12 %)  of the  1 year old mice and three  (10,2 %)  of the  18 
month old mice had reticulum cell sarcomas, type B. Four alveologenic carcino- 
mas were found, three of them in 18 month old mice. A  hemangioepithelioma 
was discovered in the liver of a  12 month old BALB/c animal. 
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FIO. 3. Spleen weights of groups of CAF1 mice given 150 X 106 BALB/c spleen cells. 
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Fro. 4, Thymus weights of groups of CAFz mice given 150 X  106 spleen cells (0--0) 
compared with  those  of control  CAF~ mice  (C)--C)). 
Experimental Mice.  371  CAF1 mice were divided into the groups shown in 
Table I. Another 49 mice, not included in that table, were killed less than 3 
FIC. 5. Preneoplastic stage of chronic allogeneic disease. (a) Germinal center (spleen) con- 
taining many tingible bodies and nuclear dust. X 250. (b) Nodular collections of plasma cells 
in a mesenteric lymph node. X 250. (c) Pleomorphic change, with a mixture of plasma cells 
and reticulum cells. X 520. (d) Prelymphoma, characterized by irregular sheets of pleomorphic 
tissue containing lymphocytes, plasma cells, and reticulum cells. X 250. ~'IG. 6. Malignant stage of chronic allogeneic disease.  (a)  Reticulum cell sarcoma, type B, 
in spleen.  X  250. (b)  Reticulurn cell sarcoma, type B, invading liver. X  250. ARMSTRONG  ET  AL.  423 
months after the administration of BALB/c spleen cells in order to obtain tis- 
sues for histologic studies. 
None of the experimental mice developed signs of runt disease. Body weight 
(Fig. 1) was slightly reduced in the control mice at 1 yr, but at all other times 
there were no significant differences in body weight between control and  ex- 
perimental mice. 
Splenomegaly was an outstanding feature of the disease. The degree of splenic 
enlargement was proportional to the number of BALB/c spleen cells adminis- 
,¢[ 
:E 
o  -I- 
o.. 
=E  >,. 
,-I 
-I- 
I,- 
F- 
Z 
W 
i,m 
I1= 
50, 
40, 
30- 
20- 
I0- 
O, 
I 
o  50 
NUMBER 
|  i  i 
I00  150  200 
Bolb/c  CELLS  (XlO 6) 
FIG. 7. Incidence of lymphomas  in CAF1 mice 1 yr after receiving  the indicated number of 
BALB/c spleen cells. 
tered (Fig.  2). The spleen enlarged early in the course of the disease and re- 
mained  enlarged for  the  duration  of  the  study  (Fig.  3).  Splenomegaly was 
usually  accompanied by  an  enlargement of lymph nodes.  Cervical,  axillary, 
periaorfic, and mesenteric lymph nodes were most frequently involved. The 
weight of the thymus was reduced, especially in the older mice (Fig. 4). 
Four kinds  of histologic changes occurred in the spleen and lymph nodes. 
Early in  the  disease,  at  1-3  months,  the lymphoid follicles were greatly en- 
larged. The bulk of the follicle consisted of a huge germinal center, which was 
filled with nuclear debris. Much of the debris lay free in the intercellular space, 
but a considerable amount was phagocytized. The result was a striking picture 
of myriad tingible bodies surrounded by nuclear dust  (Fig. 5a). The red pulp 
of the spleen was often packed with nucleated red blood cells and megakaryo- 
cytes. 
The next phase began 3-6 months after the injection of BALB/c spleen cells, 80- 
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and was characterized by intense plasmacytosis. Sheets and nodules of plasma 
cells filled the medullary portions of the lymph nodes, and frequently extended 
into their cortical zones (Fig. 5b). In the spleen, plasma cells were abundant in 
the perifollicular zone of the red pulp. This, together with the enlarged follicles, 
produced  a  marked  triple-zoning  effect.  In  some  specimens  mast  cells  were 
abundant.  Not every lymph node of a given mouse was abnormal; the mesen- 
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FIG. 8. Incidence of lymphomas in groups of CAF1 mice given 150 X  106 BALB/c cells 
(•  @) compared with that in control CAF1 mice (O-  O. 
teric lymph node was most frequently affected, and in some animals it was the 
only lymph node with important changes. 
6 months or longer after the injection of parental spleen cells a new element 
was seen. This was the appearance of numerous reticulum cells,  and in many 
instances the previously described nodular collections of plasmocytes were re- 
placed by irregular sheets of tissue consisting of plasma cells and reticulum cells 
(Fig. 5c). Whereas the former changes were readily recognized as intense hyper- 
plasia of lymphoid tissue, many examples of this third pattern were difficult to 
classify. Its pleomorphic aspect  suggested  neoplasm,  but  preservation  of the 
architecture  of the  specimen did not  corroborate this.  This lesion, which was 
tentatively diagnosed as "prelymphoma," was present in 32 mice (Fig. 5d). 
The fourth histologic pattern was that  of a  malignant lymphoma (Fig.  6). ARMSTRONG  ET  AL.  425 
The incidence of lymphomas was proportional to the number of BALB/c spleen 
cells administered (Fig. 7). The development of lymphomas in 226 CAF1 mice 
given 150 X  106 BALB/c spleen cells is compared with that in 324 control CAF1 
mice in Figs. 8 and 9. 
A  total of 93 lymphoid tumors developed. Of these, 77 were reticulum cell 
sarcomas, type B ; 1 was a type A reticulum cell sarcoma; 5 were lymphoblastic 
lymphomas; 1 was a mastocytoma; 9 were unclassified. One animal had a type 
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FIG. 9. Cumulative incidence of lymphomas in experimental and control mice. 
B neoplasm in its spleen and a lymphoblastic lymphoma in its mesenteric lymph 
node. Another mouse had an unclassifiable neoplasm in its spleen and a lympho- 
blastic tumor in a cervical lymph node. Of the 77 type B reticulum cell sarcomas, 
20 were confined to the spleen,  10 occurred only in lymph nodes, 20 involved 
both spleen and lymph nodes, and 27 had metastasized to nonlymphoid organs, 
usually the liver, kidney, and lung. The 9 unclassified lymphomas were char- 
acterized by whorls of reticulum cells alternating with  solid sheets  of mega- 
karyocytes. In five of these cases, megakaryocytes were also present in lymph 
nodes, liver, kidney, and lung. In no instance was a thymoma observed. 
Electron Microscopy.--Electron  microscopy corroborated the  observations 
made by light microscopy. The hyperplastic phase  of the  disease  was  char- 
acterized  by  three  striking  features:  (a)  numerous  macrophages  containing 426  CHRONIC  ALLOGENEIC DISEASE.  II 
extremely fine debris  (Fig.  10a);  (b)  numerous mast cells  (Fig.  10b);  and  (c) 
abundant  plasma cells.  The neoplasms were comprised of lymphoblasts (Fig. 
lla),  among which  were numerous and  conspicuous reticular cells (Fig.  llb). 
The over-all picture was typical of a  reticulum cell sarcoma. 
Despite a  fastidious search through numerous specimens, no virus particles 
were seen. 
Transplantation of Tumors.--Cell suspensions of the spleens of 51  experimen- 
tal mice were injected  into litters  of infant  syngeneic mice. The donors  were 
selected because,  at the  time of autopsy,  their spleens were greatly enlarged. 
Subsequent  histologic analysis of these  transplanted  tissues  revealed the fol- 
lowing diagnoses: hyperplasia in  17,  prelymphoma in 5,  malignant lymphoma 
in  29.  Reticulum  cell  sarcomas developed in recipients of: 2  of the  17 hyper- 
plastic spleens, 3 of the 5 spleens diagnosed as prelymphoma, and 19 of the 29 
spleens  containing  malignant  lymphoma.  In  the  latter  group,  seven  spleens 
diagnosed as unclassified lymphoma were transplanted  and four of these took 
in the recipients;  in each instance the neoplasm in  the recipient had the mor- 
phology typical of a  reticulum cell sarcoma, type B.  Primary neoplasms were 
also  injected  simultaneously into  syngeneic and  either  parental  or  allogeneic 
infants, or into both. In 11 instances the tumor grew in at least one kind of re- 
cipient. The results are shown in Table II. In the two cases where the primary 
tumor took in both CAF1 and BALB/c animals, it also grew in allogeneic mice. 
Cytotoxicity  Tests.--The cells of eight tumors were tested for their ability to 
absorb  antibody  activity from alloantisera.  Fig.  12  shows  the  results  of  the 
antiserum being directed against H-2.5,  a  specificity present  in  the A/J  par- 
ent  of  CAF1  and  absent from its  BALB/c  parent. In  each  case,  the  tumor 
cells were capable of absorbing antibody activity from this serum. Specificity of 
the test is demonstrated in Fig.  13,  which shows that the tumor cells failed to 
absorb antibody activity from an antiserum directed against H-2.2, a specificity 
found  on  C57B1/10Sn  cells,  but  absent from CAF1  cells.  Live cells from five 
tumors  were  labeled  with  5~Cr and  were  reacted  directly  with  alloantisera 
directed  against  specificities  present  on  BALB/c  cells,  but  not  on  A/J  cells 
(H-2.31);  or  present  on  A/J  cells,  but  not  on  BALB/c  cells  (H-2.1,  H-2.5, 
H-2.11,  H-2.23);  or not present on  either BALB/c or A/J cells  (H-2.2).  The 
results (Table III) show that the tumors contained the specificities contained in 
CAF1 cells. 
Assays for Chimerism.--The  spleens of 52  experimental mice were analyzed 
for the presence of BALB/c cells by the spleen assay method of Simonsen. In 
FIG. 10. Preneoplastic phase of chronic allogenelc disease. (a) A portion of the cytoplasm 
of a  macrophage (M)  is shown. Note  the abundant  debris and  its fine, intricate  pattern 
(arrows). A plasma cell (P) and several lymphocytes (L) are also seen. X 8000. (b) A nest of 
mast cells (M), among which rare lymphocytes (L), reticular cells (RC), and red blood cells 
(rbc) are  visible. X  3500. ARMSTRONG  ET  AL.  429 
this technique,  about 10 X  10  ~ spleen cells of the suspected chimera are inocu- 
lated into 8-day-old syngeneic F1 hybrids.  1  wk later  the  infant  recipients  are 
killed  and  their  spleen  and body weights  compared with  those  of uninjected 
litter  mates by means  of a  spleen index,  which is the ratio  of spleen  to body 
weight. An index of 1.00 indicates n o change in spleen weight; doubling of spleen 
weight yields an index of 2.00. If parental cells with anti-F~ reactivity are pres- 
ent in the donor inoculum, splenomegaly occurs in the test mice. In the parent- 
hybrid combinations studied,  the minimum spleen index  of significance is  1.5. 
The  52  experimental  CAFt mice had  received  BALB/c spleen  cells  at  times 
TABLE II 
Transplantation  of Tumors into Syngeneic, Parental,  or AUogeneic Mice 
Tumor No. 
Growth in 
CAFt  BALB/c  Allogenic  mice 
C36-6  + *  0:~  ND § 
C76-45  +  +  + 
C1840  +  +  + 
C 117-69  +  ND  + 
Cl17-66  +  0  ND 
C17-5  +  0  ND 
CV17-69  +  0  0 
C18-42  +  0  0 
C18-13  +  ND  + 
C 125-42  +  0  ND 
CV126-40  +  0  ND 
* +, take. 
0, no take. 
§ ND, not done. 
varying from 1 wk to 1 yr prior to the assay. In only one instance did the inocu- 
lation of spleen  cells from the  experimental  mice produce a  significant spleen 
index (Fig.  14). 
The spleens  of an additional  23 experimental  mice were analyzed by means 
of the discriminant spleen assay. In this technique,  spleen cells of the putative 
chimera are injected simultaneously into syngeneic and allogeneic F1 hybrids; 
both test hybrids are semiallogeneic with respect to the parental  donor of the 
original experimental animal. For example, the test hybrids used were (BALB/c 
FIG. 11. Neoplastic phase of chronic Mlogenelc  disease. (a) Lymphoblast: the large nucleolus 
(n) and the dense cytoplasm studded with ribosomes (arrow) are characteristic  of this  type 
of cell. X  7200. (b)  Reticular  cell: the nucleus  (N)  is irregularly  shaped  and has  a  finely 
scattered  chromatin,  but the large nucleolus typical of this cell is not seen here. The cyto- 
plasm  is  packed  with  ribosomes  (arrows)  and  contains  numerous  mitochondria  (m)  and 
vacuoles (v). X  8000. 430  CHRONIC  ALLOGENEIC  DISEASE.  II 
X  A/J)F1  and  (BALB/c  X  C57B1/6)F~,  and  the  experimental  animals, 
(BALB  X  A/J)F~, had been injected with BALB/c spleen cells.  6 of 23  CAF1 
mice analyzed in  this  way had  received  the  BALB/c  spleen  cells  24  hr pre- 
viously. In each of the mice so studied a significant spleen index occurred in the 
(BALB/c X  C57B1/6)  F1 recipient, but not in the (BALB/c  X  A/J)F~ recipi- 
ent (Fig.  15). 
60 
I'- 
> 
--  50 
(,J 
0 
40  LL 
0 
hi 
I,I 
,.El  ,,,  50 
E 
,~0  ¸  . 
0  1.56  3.125  6,25  12.5  25  50 
INHIBITOR  CONCENTRATION  (  X  10  6 Cells/ml) 
FIo. 12. Cytotoxicity assay based on release  of ~ICr  from A/J target cells. The alloantiserum 
was directed against H-2.5, a specificity  present on A/J cells, but not BALB/c ceils. Absorp- 
tion by normal CAF1 lymphocytes is shown by the open triangles; absorption by the tumors 
is indicated by the closed triangles. Results obtained when BALB/c cells were used for absorp- 
tion are shown by the open circles. 
The results shown in Figs.  14 and 15 indicate that the donor (BALB/c) cells 
lost their ability to react against CAF1 antigens within 24 hr of their inocula- 
tion. However, some BALB/c cells persisted in their CAF1 hosts, and they were 
detectable in 23 out of 23 cases by their reactivity against (BALB/c ;4 C57B1/ 
6)F1 antigens (Fig. 15, right panel). 
Since  the  lower  limit  of sensitivity  of  the  spleen  assay  is  between  5  and 
10  X  106  cells,  another method  was  tried  in  an  attempt  to detect  BALB/c 
cells with  antihost  activity in  the experimental mice. Adult  CAF1  mice were 
given 950 R  total body x-irradiation and, within 6 hr, 70 ;4 106 spleen cells from 
CAF, mice that had been injected with 200 X  106 BALB/c spleen cells 1 month 
earlier. If BALB/c ceils  with anti-CAF1 activity" were present  in  the restoring ARMSTRONG  ~ET  AL.  431 
inoculum, a graft-versus-host  reaction could occur in the irradiated test animal. 
The survival of  these mice was compared with four  other  groups of lethally 
irradiated  CAF1  mice:  (a)  12 mice given no  other  treatment;  (b)  12  mice re- 
stored with 70 X  106 normal CAF1 spleen cells; (c) 12 mice restored with a mix- 
ture of 60  X  106 CAF1 spleen cells plus I0 X  106 BALB/c spleen cells; (d)  12 
mice restored  with  a  mixture  of  60  X  106  CAF1  spleen  cells plus  10  X  106 
spleen  cells from BALB/c mice sensitized  by two  doses  of  150  X  106  CAF1 
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FIo. 13. Cytotoxicity assay employing an aUoanfiserum  against H-2.2, a specificity  present 
on C57B1/10Sn cells, but absent from CAF1 cells. Absorption with  C57B1/10Sn cells is 
shown by the closed circles. Cells from two CAF1 tumors (open and closed triangles) failed to 
absorb antibody activity from this serum. 
spleen cells, All mice of group (a) were dead within 10 days; all mice of group (b) 
survived longer than 3 months. Results of the remaining groups are shown in 
Fig.  16. The irradiated recipients of spleen cells from experimental CAFI mice 
developed  typical  secondary  disease,  and  75%  of  them  were  dead  within  a 
month. This result indicates that BALB/c cells with anti-CAF1 activity were 
present in the experimental mice. 
DISCUSSION 
The incidence of lymphoid neoplasms in our group of 18-month-old BALB/c 
mice was 10.3 %, which corresponds with Deringer's (14)  results in 182 retired 
breeders  o[  the  subline  BALB/cAnDe.  Lymphomas occurred  in  CAFI mice 432  CHRONIC  ALLOGENEIC  DISEASE.  II 
even less frequently. At the age of 24 months, 3 out of 65 (4.5 %) of the animals 
had lymphomas, and the cumulative incidence in 324 mice studied over a 2 yr 
period was only 3 %. By contrast, the incidence of lymphomas in CAF1 mice 
injected with BALB/c spleen cells was much higher. For example, more than 
half the 18-month-old animals treated in this manner had lymphoid neoplasms. 
These results confirm and extend our previous experiments in (C57B1/6 X 
DBA/2)F1 mice injected with C57B1/6 spleen cells  (5). Studies of others have 
also shown  that  the  administration  of allogeneic or semiallogeneic lymphoid 
cells results  in  a  high  incidence of neoplasms.  Walford  and Hildemann  (15) 
injected newborn C3H mice with  spleen cells from adult mice of a  congenic 
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FIG. 14. Results of Simonsen assay, in which spleen cells  from either BALB/c (open  circles) 
or experimental  CAF1 (closed  circles) were injected into newborn CAF1 mice. 
strain,  C3H.K, differing from the recipient line only at  the weak H-1  histo- 
compatibility locus.  Both  the  rate  of appearance  and  the  incidence of lym- 
phomas  were  increased  in  the  recipients.  Walford  (16)  later extended these 
experiments by injecting either C3H (H-I  S) or C3H. K  (H-1  b) spleen cells into 
either  C3H  or  C3H. K  newborn mice.  A  high  incidence  of lymphomas was 
found  only in  recipients  of allogeneic spleen  cells.  Keast  and  Stanley  (17), 
however, did not find an increased incidence of neoplasms in PH mice injected 
at birth with allogeneic spleen cells. Dawson, Cauchi, and Field (18)  reported 
the  development of neoplasms in  F1 hybrid rats given parental spleen cells; 
17 % of the animals developed tumors, most commonly fibrosarcomas. Unfor- 
tunately, they failed to mention the incidence of tumors in untreated animals 
of tbe same strain. A high proportion of senti-inbred Holtzman  rats  develop 
lymphosarcomas when joined in parabiosis (19).  Of 242 pairs of rats examined ARMSTRONG  ET  AL.  433 
from 7-29 months after the parabiotic union, 44 %  had neoplasms.  None of a 
large series of single, control rats had developed a tumor within that time. It is 
of considerable  interest  that when one of the parabionts  was treated  with  an 
otherwise lethal dose of x-irradiation just prior to the anastomosis, neither the 
irradiated  animals  nor  their  partners  developed  lymphosarcomas  (20).  This 
suggests  that  an interaction  among radiosensitive  cells  (lymphocytes?)  of the 
allogeneic partners is required for development of the lymphomas. 
As part of his extensive studies on the pathogenesis of leukemia in AKR mice, 
which uniformly develop  a  th)anic  lymphoma around  the  age  of  1 yr,  Met- 
calf  (21)  found that the incidence of tumors was increased in F1 hybrid recip- 
TABLE III 
Cytotoxic  Test Using  CAF1 Tumors as Target Cdls 
Source  of Target Cells 
C' plus 
normal 
mouse 
serum 
C' plus alloantiserumvs.  H-2 specificities 
2  1  5  11  23  31 
Normal BALB/c ..........  24.4*  18.4  38.5  18.5  18.6  30.9  76.6 
Normal CAF1 .............  26.9  25.1  68.9  72.5  41.6  71.6  71.0 
CAF1 Tumors 
CV109-4 ...............  33.4  28,0  69.4  64.2  49.2  67.3  71.7 
CV109-5 ...............  29.7  26.9  68.1  63.2  45.7  68.3  73.6 
CV117-90-1C:~-1  ........  30.7  28.2  69.6  70.5  48.0  70.2  70.1 
CVl17-69-2C*-1  ........  25.5  21.2  67.7  72.1  46.8  71.0  72.2 
CVl17-69-2C~:-2 ........  26.5  25.1  68.9  70.8  44.4  72.6  70.4 
* % release of total radioactivity. 
:~ After serial passage in syngeneic recipients. 
ients of parental AKR spleen cells. Most of the  neoplasms  were  derived  from 
AKR cells, as judged by transplantation tests. When the results were analyzed 
in terms  of the  age of the  iniected  cells,  the incidence of leukemia  in the re- 
cipients coincided with that in the donor line. Metcalf concluded that the AKR 
cells persisted in the F1 and ultimately became neoplastic,  just as they would 
have  if left in  situ.  Our experimental  model thus  differs  from his in two im- 
portant ways: the donors we used have a low incidence of neoplasms,  and the 
tumors we found originated in cells of the host. 
Two  lines  of  evidence  demonstrate  the  origin  of  the  neoplasms  in  CAF1 
mice injected  with BALB/c spleen  cells.  In seven of the  nine  cases where  it 
was  possible  to  transplant  tumor  cells  simultaneously  into  infant  F~  and 
BALB/c mice,  only the  F~  mice  accepted  the  tumor.  In  the  two  other  in- 
stances the tumor grew in allogeneic as well as parental  recipients,  suggesting 
the  loss  of histocompatibility  antigens.  Perhaps  more  convincing are  the  re- 
suits of the cytotoxicity assay. Every tumor examined by this method possessed 
1-1-2 antigens  characteristic  of the  F1 host. 434  CItRONIC  ALLOGENEIC  DISEASE.  II 
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How normal lymphoid ceils provoke the development of lymphomas in their 
semiallogeneic  hosts  is  unknown.  Debilitating  runt  disease  may  be  a  con- 
tributing factor. It must be emphasized, however, that we have chosen experi- 
mental conditions that do not lead to the development of runt disease. For this 
reason, we believe that Keast's  (22)  experiments, in which he induced "runt- 
ing" with allogeneic spleen cells,  cortisone, bacterial vaccines, or virus inocu- 
lations and failed to produce a high incidence of neoplasms, are irrelevant to 
our results. Atrophy of the thymus, which occurs in chronic allogeneic disease, 
could impair the recipient's resistance  to neoplastic ceils. However, destruc- 
tion of the thymus was usually incomplete, the paracortical (thymus-dependent) 
(23) zone of the lymph nodes was not depleted of lymphocytes, and no correla- 
tion was found between thymus weight and the incidence of lymphoma. 
The persistent splenomegaly in chronic allogeneic disease is most likely due to 
proliferation of host cells because the spleen assay results,  which confirm an 
earlier report by Simonseu (24), indicate that the donor inoculum rapidly ac- 
quires tolerance to host antigens. However, when irradiated F1 recipients were 
used in  the bioassay (Fig.  13),  parental cells  with antihost activity could be 
detected. Their number was probably less than 107  , which is below the limits of 
detection of the  spleen  cell  assay.  Since  200  X  106  BALB/c cells were  ad- 
ministered to the experimental animals,  we estimate  that  about 95 %  of the 
parental  inoculum  loses  anti-CAF1  activity within  24  hr  of  its  inoculation. 
The host's lymphoid reaction, which has also been observed in acute allogeneic 
disease  (25),  is  an  unexpected  one.  According  to  orthodox  transplantation 
genetics,  a  hybrid-antiparent  response  cannot  occur. However, certain  phe- 
nomena, such as poor growth of parental line tumors in F~ hosts (26)  and the 
deficient growth  of  parental  bone  marrow  in  heavily irradiated  F1  animals 
(27),  suggest  the  likelihood of such  a  response.  Myburgh  (28)  has  recently 
reported the development of anemia in both parabionts  of a  combination in 
which one member of the pair was an F1 hybrid and the other a parental line 
mouse. He attributed this result to a hybrid-antiparent reaction. It is unlikely 
that  the  marked  lymphoproliferative  reaction  we  observed  is  due  to  this 
mechanism, which is too weak to cause rejection of parental skin grafts by F1 
hybrid recipients (29). 
To  what  are  these  animals  responding?  From  the  morphology  of  their 
lymphoid tissue,  the instigator  should be a  powerful and persistent  antigen; 
this  raises  the question whether an  antigenic stimulus can lead to neoplasia. 
Metcalf (30) injected C3H mice once a week for months with either Salmonella 
adelaide flagellar antigen, bovine serum albumin, or saline. Animals given salipe 
injections had  a  13%  incidence of lymphomas;  19%  of those given the Sal- 
monella antigen had tumors; and 31% of the mice challenged repeatedly with 
bovine serum albumin had reticular neoplasms, many of which were plasma 
cell tumors. Balls and Ruben (31) have made a fascinating study in cold-blooded 
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fragments  of  normal kidneys  from European  newts  (Triturus  cristatus)  into 
the  forelimbs  of African  clawed  toads  (Xenopus  laevis).  Half  the  recipients 
developed a lymphosarcoma at the site of the  implant following  its  rejection. 
In other experiments they found that implants of allogeneic liver, spleen, and 
muscle, as well as xenogeneic kidney, had the same effect. Implants into the 
forelimb of an adenocarcinoma from Rana pipiens also induced lymphosarcoma 
in Xenopus laevis, but  implantation  of the  adenocarcinoma into  the  anterior 
chamber of the  eye failed to induce  tumors. This indicates that the lympho- 
sarcomas in the recipients were not due simply to transfer of a virus because 
there  is no  immunologic response to  avascular intraocular  transplants 1 (32). 
The development of neoplasms in recipients of human renal allografts is just 
now emerging (33).  This has been attributed  to immunosuppression,  but  the 
fact  that  the  majority  of  these  tumors  arise  in  lymphoid  tissue  seems  not 
entirely explainable in  this way.  Could  these lymphomas be another demon- 
stration of the consequences of a prolonged immune response? 
The possibility that the tumors we observed are caused by a virus must be 
considered.  Transmission of an infective virus from donor to host seems un- 
likely as the sole cause of the tumors, since frozen and thawed BALB/c cells 
were ineffective in producing  disease.  Furthermore,  infective mouse leukemia 
virus can rarely be demonstrated in the tissues of BALB/c mice younger than 
2 months of age.  2 Walford 06)  also discounted this possibility because, in his 
work, augmented tumor development occurred only when lymphoid cells were 
transplanted  across  a  histocompatibility  barrier.  It  is  conceivable  that  the 
parental graft injures host cells,  thereby activating a  latent virus.  Continued 
proliferation  of  such  a  virus  could  provide  the  antigen  responsible  for  the 
massive hyperplasia of lymphoid tissue.  It may be unnecessary  to postulate 
the presence of a  conventional oncogenic virus; all that may be needed  is a 
self-replicating  antigen  of  sufficient  immunogenicity  to  stimulate  the  host's 
lymphoid tissue. Thus far, no viruses have been seen by electron microscopy, 
and attempts to transmit the tumors by injecting cell-free filtrates of affected 
tissues  into  newborn  mice have failed.  But  such  negative  results  are  incon- 
clusive, and work along these lines is continuing. 
The  similarities  between  chronic  allogeneic  disease  and  the  spontaneous 
disorder of New Zealand Black  (NZB)  mice and their hybrids is striking.  In 
both cases, severe glomerulonephritis of the immune deposit variety develops 
(34),  and in both instances there is a high incidence of malignant lymphomas 
(35). Chronic allogeneic disease is induced by immunocytes that are introduced 
into the animal with a needle and syringe. NZB disease occurs  spontaneously, 
perhaps because of a  unique  genetic  abnormality.  In  both  chronic  allogeneic 
I In a forthcoming paper we will show that enclosure of immunocompetent parental cells 
in a cell-impermeable  chamber does not provoke disease in FI recipients. 
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disease and NZB disease, marked hyperplasia of lymphoid tissue precedes the 
development of lymphomas (36).  Murine  leukemia virus has been implicated 
in NZB disease (37), but the specificity of this finding  is unclear  since  though 
almost all mice carry these agents, only NZB mice spontaneously develop auto- 
immune disease (38). A more anterior defect may exist in these animals, and we 
propose that, whatever its nature,  it is shared by animals undergoing chronic 
allogeneic reactions. 
Finally, immunocompetent cells with antiself activity  must  now  be  added 
to the list of factors that can trigger the development of a neoplasm. Whether 
or not  analogous  cells can arise spontaneously, by mutation or  as  the  result 
of a  viral or chemical action,  remains to be demonstrated.  Fortunately,  new 
techniques are now available to test this hypothesis. 
SUMMARY 
The incidence of lymphomas in 371  CAF1 mice injected with BALB/c spleen 
cells was compared with that  in 324  control CAF1 mice. A  high incidence  of 
lymphomas was found in the treated mice, but not in the control animals. The 
development of the neoplasms was a function of the number of parental cells 
administered.  Analyses  of  the  injected  mice for  the  presence  of  donor  cells 
indicated that the majority of the injected parental ceils lost antihost activity, 
probably within 24 hr of their administration. The tumors were of host origin, 
as judged by transplantation tests and antigenic analysis of tumor ceils. 
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